Literature DB >> 7750206

Expression of antisense epidermal growth factor receptor RNA downmodulates the malignant behavior of human colon cancer cells.

S Chakrabarty1, S Rajagopal, S Huang.   

Abstract

Human colon cancer (Moser) cells produce and secrete epidermal growth factor (EGF) and respond to EGF via an autocrine/paracrine mode through the cell surface EGF receptor (EGFR). In this report we show that EGF promotes the malignant behavior of the Moser cells in vitro in terms of growth in soft agarose and invasion of Matrigel-coated porous membranes. Expressing antisense EGFR RNA in the Moser cells (through transfection with an inducible antisense EGFR expression vector) downmodulated the expression of cell surface EGFR and EGFR mRNA with a concurrent inhibition of growth in soft agarose and invasion of Matrigel-coated membranes. In addition, the ability of exogenously applied EGF in promoting the malignant behavior of these cells was circumvented. We conclude that antisense EGFR RNA was a potent agent in circumventing the in vitro malignant properties of the Moser cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7750206     DOI: 10.1007/BF00132207

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  16 in total

Review 1.  Growth factors in development, transformation, and tumorigenesis.

Authors:  M Cross; T M Dexter
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

2.  Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor.

Authors:  D F Stern; D L Hare; M A Cecchini; R A Weinberg
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

3.  Activation of a heterologous promoter in response to dexamethasone and cadmium by metallothionein gene 5'-flanking DNA.

Authors:  M Karin; A Haslinger; H Holtgreve; G Cathala; E Slater; J D Baxter
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

4.  Modulation of differentiation and proliferation in human colon carcinoma cells by transforming growth factor beta 1 and beta 2.

Authors:  S Chakrabarty; D Fan; J Varani
Journal:  Int J Cancer       Date:  1990-09-15       Impact factor: 7.396

Review 5.  Heterogeneity of human colon carcinoma.

Authors:  M G Brattain; A E Levine; S Chakrabarty; L C Yeoman; J K Willson; B Long
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  Immunotherapy with antibodies to the EGF receptor.

Authors:  C Dean; H Modjtahedi; S Eccles; G Box; J Styles
Journal:  Int J Cancer Suppl       Date:  1994

7.  Growth modulation by epidermal growth factor (EGF) in human colonic carcinoma cells: constitutive expression of the human EGF gene.

Authors:  S A Huang; P F Lin; D Fan; J E Price; J M Trujillo; S Chakrabarty
Journal:  J Cell Physiol       Date:  1991-08       Impact factor: 6.384

8.  Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor content in normal and carcinomatous gastric and colonic tissue.

Authors:  P Borlinghaus; S Wieser; R Lamerz
Journal:  Clin Investig       Date:  1993-11

9.  Expression of several growth factors and their receptor genes in human colon carcinomas.

Authors:  M Ito; K Yoshida; E Kyo; A Ayhan; H Nakayama; W Yasui; H Ito; E Tahara
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1990

10.  Transforming growth factor alpha and epidermal growth factor levels in normal human gastrointestinal mucosa.

Authors:  S A Cartlidge; J B Elder
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

View more
  10 in total

1.  Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities.

Authors:  K Hida; M Shindoh; M Yasuda; M Hanzawa; K Funaoka; T Kohgo; A Amemiya; Y Totsuka; K Yoshida; K Fujinaga
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

2.  EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells.

Authors:  T Turner; P Chen; L J Goodly; A Wells
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

3.  Epidermal growth factor modulates cell attachment to hyaluronic acid by the cell surface glycoprotein CD44.

Authors:  M Zhang; R K Singh; M H Wang; A Wells; G P Siegal
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

4.  Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer.

Authors:  H Kuniyasu; W Yasui; H Shinohara; S Yano; L M Ellis; M R Wilson; C D Bucana; T Rikita; E Tahara; I J Fidler
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

5.  Neurotensin stimulates expression of early growth response gene-1 and EGF receptor through MAP kinase activation in human colonic epithelial cells.

Authors:  Dezheng Zhao; Yanai Zhan; Huiyan Zeng; Hon Wai Koon; Mary P Moyer; Charalabos Pothoulakis
Journal:  Int J Cancer       Date:  2007-04-15       Impact factor: 7.396

Review 6.  Beta-catenin--a linchpin in colorectal carcinogenesis?

Authors:  Newton Alexander Chiang Shuek Wong; Massimo Pignatelli
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

7.  Effects of epidermal growth factor and its signal transduction inhibitors on apoptosis in human colorectal cancer cells.

Authors:  Jane C J Chao; Wen Li Peng; Sheng-Hsuan Chen
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

8.  In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022.

Authors:  H L McLeod; V G Brunton; N Eckardt; M J Lear; D J Robins; P Workman; M A Graham
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

9.  Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.

Authors:  C S Swindle; K T Tran; T D Johnson; P Banerjee; A M Mayes; L Griffith; A Wells
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

10.  Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor.

Authors:  X X Tian; J Y Chan; J C Pang; J Chen; J H He; T S To; S F Leung; H K Ng
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.